Sarin. P S PS; Sun. D K DK; Thornton. A H AH; Naylor. P H PH; Goldstein. A L AL
A lab study found that antibodies made against the peptide thymosin‑alpha‑1 could block HIV‑like virus replication in cultured cells, likely because part of the peptide looks similar to a piece of the virus’s core protein. This suggests a possible vaccine angle, but it doesn’t show that taking thymosin‑alpha‑1 itself helps with HIV or any other health goal.
Haritos. A A AA; Salvin. S B SB; Blacher. R R; Stein. S S; Horecker. B L BL
Researchers found a new rat peptide called parathymosin alpha that looks a bit like thymosin‑alpha‑1, but it’s missing a key piece and reacts differently with antibodies. In mice it seems to help another protein protect against a fungal infection, but there’s no human data or dosing info.
Scientists figured out how to pull out the peptide thymosin‑alpha‑1 from calf spleen using a series of chemical steps and chromatography, confirming it’s the same peptide found in thymus tissue.
Haritos. A A AA; Goodall. G J GJ; Horecker. B L BL
Scientists found that the main form of thymosin alpha‑1 in rat thymus is actually part of a larger 112‑amino‑acid protein called prothymosin alpha, which tends to stick together in groups of three and is very acidic. This study is about how the protein looks and behaves, not about how to use it in people.
The paper shows that the mRNA for thymosin‑alpha‑1 can be efficiently made into protein in a wheat‑germ cell‑free system, that the polyamine spermidine speeds up the translation, and that the peptide gets an acetyl group attached during its synthesis.
Hersh. E M EM; Reuben. J M JM; Mansell. P W PW; Rios. A A; Gutterman. J U JU; Munn. G G; Murray. J L...
The study looked at immune system measurements in people with AIDS and found that many immune cells and a protein called thymosin‑alpha‑1 get worse as the disease gets more advanced, but it didn’t test giving thymosin‑alpha‑1 as a treatment.
Lee. C A CA; Bofill. M M; Janossy. G G; Thomas. H C HC; Rizza. C R CR; Kernoff. P B PB
The study looked at English haemophilia patients who got clotting factor concentrates from blood products and found they often had immune system quirks, like altered T‑cell ratios and higher levels of a protein called alpha‑1‑thymosin. These changes were linked to how much blood product they received, not the donor source, and were more common in adults and those with haemophilia A.
Scientists used computer simulations to see how the peptide thymosin‑alpha‑1 (called zadaxin) can slip into tiny carbon tubes. They found that only tubes about 1.9 nm wide and of a certain length let the peptide enter, and that the surrounding water level changes whether the peptide prefers the tube or the water.
Removing the thymus in unborn monkeys messes up their ovarian development, raising some hormones and lowering others, but it doesn't change the level of the peptide thymosin‑alpha‑1. The study shows the thymus helps early ovarian growth, but it doesn't tell us how to use thymosin‑alpha‑1 in adults.
Savino. W W; Manganella. G G; Verley. J M JM; Wolff. A A; Berrih. S S; Levasseur. P P; Binet. J P JP...
The study shows that certain thymus tumors (thymomas) can make thymic hormones like thymosin‑alpha‑1, but these tumor cells lack some immune‑system markers (MHC class II). This is mainly a cancer‑biology finding and doesn’t give any new tips on how to take or dose thymosin‑alpha‑1 for health purposes.
Haynes. B F BF; Scearce. R M RM; Lobach. D F DF; Hensley. L L LL
This study maps the thymus and shows that the hormone‑like peptide thymosin‑alpha‑1 is naturally found in a specific type of thymic epithelial cell, not in the surrounding fibrous tissue. It’s a basic anatomy paper, not a trial of taking the peptide for health benefits.
Dalakas. M C MC; Engel. W K WK; McClure. J E JE; Goldstein. A L AL; Askanas. V V
The study shows that the peptide thymosin‑alpha‑1 is made by cells in the thymus and that people with myasthenia gravis have a lot more of it in those cells, which might worsen their autoimmune disease. It doesn’t give any new ways to use the peptide for health or performance, just a clue about why removing the thymus can help these patients.
Kater. L L; Oosterom. R R; McClure. J J; Goldstein. A L AL
The study shows that human thymus cells release substances similar to thymosin fractions 5 and 6 that boost T‑cell activity, but thymosin‑alpha‑1 doesn’t seem to play a role in this effect. Antibodies blocking fractions 5 and 6 stop the boost, while those against thymosin‑alpha‑1 do not.
The paper explains a lab chemistry method for building the C‑terminal half of the peptide thymosin‑alpha‑1 using a polymer‑bound reagent, but it doesn’t test any health effects or give dosing advice.
Poo. Jorge Luis JL; Sánchez-Avila. F F; Kershenobich. D D; García-Samper. X X; Gongora. J...
A small pilot study gave 23 people who hadn't responded to standard hepatitis C treatment a combo of three drugs: peginterferon, ribavirin, and the peptide thymosin‑alpha‑1. After 12 weeks about 61% showed a drop in virus levels, and after 24 weeks about 48% still had a response. The results are promising for hard‑to‑treat hepatitis C patients but don't offer a new health hack for most people.
The study shows that thymosin‑alpha‑1 only barely interacts with the same gut receptors that the hormone VIP uses. It is far weaker—about 1,500 times less potent—at blocking VIP binding and only slightly raises cellular signaling (cAMP). In short, thymosin‑alpha‑1 isn’t a strong activator of these VIP receptors.
Freire. M M; Hannappel. E E; Rey. M M; Freire. J M JM; Kido. H H; Horecker. B L BL
Scientists isolated a piece of RNA from calf thymus that makes a protein about 16,000‑17,000 daltons in size, and this protein includes the short thymosin‑alpha‑1 sequence. The study shows that the larger protein is the main product when the RNA is used in a test‑tube protein‑making system.
Scientists used a special antibody and tetanus toxin to map parts of the human and rodent thymus, showing that certain thymus cells contain the peptide thymosin‑alpha‑1. The study is basic research and doesn’t give any new ways to use the peptide for health or performance.
Hall. N R NR; McClure. J E JE; Hu. S K SK; Tare. N S NS; Seals. C M CM; Goldstein. A L AL
In mice, a chemical called 6‑hydroxydopamine lowered the first‑time antibody response to a foreign protein and caused a short‑term rise in the natural immune peptide thymosin‑alpha‑1, which went back to normal after a few days. The study mainly explores how stress hormones affect immunity, not how to use thymosin‑alpha‑1 as a supplement.
Hersh. E M EM; Reuben. J M JM; Mansell. P W PW; Rios. A A; Newell. G R GR; Frank. J J; Goldstein. A...
The study measured immune markers in men with early signs of AIDS and found they had low helper T‑cells, an inverted helper‑to‑suppressor ratio, low monocytes, but surprisingly high levels of the peptide thymosin‑alpha‑1 in their blood. No thymosin‑alpha‑1 was given, and the paper only suggests testing immune‑boosting drugs, not how to use the peptide for health.